Unfolding tyrosine kinase inhibitor sensitivity in chronic myeloid leukemia

被引：2
|
作者：
Perrotti, Danilo [1 ]
Neviani, Paolo [1 ]
机构：
[1] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
来源：
CELL CYCLE | 2012年 / 11卷 / 23期
关键词：
PATHWAY; GRP78;
D O I：
10.4161/cc.22808
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：4300 / 4301
页数：2
相关论文
共 50 条
  • [1] Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
    Mario Tiribelli
    Ahmet Emre Eskazan
    [J]. Oncology and Therapy, 2019, 7 : 95 - 100
  • [2] Mechanisms of tyrosine kinase inhibitor resistance in chronic myeloid leukemia
    Eiring, Anna M.
    Ellwood, Rebecca
    Fiol, Carme Ripoll
    Hills, Robert K.
    Nteliopoulos, Georgios
    Reid, Alistair
    Milojkovic, Dragana
    Apperley, Jane
    Sorouri-Khorashad, Jamshid
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [3] Chronic Myeloid Leukemia—the Promise of Tyrosine Kinase Inhibitor Discontinuation
    Ravi Kishore Narra
    Kathryn E. Flynn
    Ehab Atallah
    [J]. Current Hematologic Malignancy Reports, 2017, 12 : 415 - 423
  • [4] Tailoring Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia
    Mauro, Michael J.
    [J]. CANCER CONTROL, 2009, 16 (02) : 108 - 121
  • [5] Predictors of tyrosine kinase inhibitor treatment for chronic myeloid leukemia
    Cole, Ashley L.
    Wood, William A.
    Muluneh, Benyam
    Lund, Jennifer L.
    Lafata, Jennifer Elston
    Dusetzina, Stacie B.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 104 - 105
  • [6] Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
    Tiribelli, Mario
    Eskazan, Ahmet Emre
    [J]. ONCOLOGY AND THERAPY, 2019, 7 (02) : 95 - 100
  • [7] Precision tyrosine kinase inhibitor dosing in chronic myeloid leukemia?
    Saglio, Giuseppe
    Fava, Carmen
    Gale, Robert Peter
    [J]. HAEMATOLOGICA, 2019, 104 (05) : 862 - 864
  • [8] Chronic Myeloid Leukemia-the Promise of Tyrosine Kinase Inhibitor Discontinuation
    Narra, Ravi Kishore
    Flynn, Kathryn E.
    Atallah, Ehab
    [J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (05) : 415 - 423
  • [9] Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia
    Gater, Adam
    Heron, Louise
    Abetz-Webb, Linda
    Coombs, John
    Simmons, Jeff
    Guilhot, Francois
    Rea, Delphine
    [J]. LEUKEMIA RESEARCH, 2012, 36 (07) : 817 - 825
  • [10] Dose optimization of tyrosine kinase inhibitor therapy in chronic myeloid leukemia
    Umezawa, Yoshihiro
    Sasaki, Koji
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (01) : 24 - 29
12345